Inhalation Sciences

About:

Inhalation Sciences develops and sells patented, highly innovative labtech equipment for inhalation research

Top Investors: Sciety, Almi Invest, Stockholm Business Angels, STOAF

Description:

The PreciseInhale patented aerosol generation R&D platform delivers respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, significantly accelerating drug development timelines. The platform’s one-animal-at-a-time system requires just milligrams, not grams of costly test substance for a full PK study and delivers high-resolution lung data of, typically, <10% SD. We carry out Contract Research for novel and generic inhalation drug developers, toxicology and environmental research institutes and university research institutes in the inhalation and aerosolization field.

Total Funding Amount:

$1.16M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Novomirgorod, Kirovohrads'ka Oblast', Ukraine

Founded Date:

2004-01-01

Contact Email:

contact(AT)inhalation.se

Founders:

Per Gerde

Number of Employees:

1-10

Last Funding Date:

2023-05-25

IPO Status:

Public

Industries: